Cargando…

Epstein Barr Virus-Encoded EBNA1 Interference with MHC Class I Antigen Presentation Reveals a Close Correlation between mRNA Translation Initiation and Antigen Presentation

Viruses are known to employ different strategies to manipulate the major histocompatibility (MHC) class I antigen presentation pathway to avoid recognition of the infected host cell by the immune system. However, viral control of antigen presentation via the processes that supply and select antigeni...

Descripción completa

Detalles Bibliográficos
Autores principales:	Apcher, Sebastien, Daskalogianni, Chrysoula, Manoury, Benedicte, Fåhraeus, Robin
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2954899/ https://www.ncbi.nlm.nih.gov/pubmed/20976201 http://dx.doi.org/10.1371/journal.ppat.1001151

Ejemplares similares

Exosome-driven transfer of tumor-associated Pioneer Translation Products (TA-PTPs) for the MHC class I cross-presentation pathway
por: Duvallet, Emilie, et al.
Publicado: (2016)

A yeast-based assay identifies drugs that interfere with immune evasion of the Epstein-Barr virus
por: Voisset, Cécile, et al.
Publicado: (2014)

Major histocompatibility class I antigenic peptides derived from translation of pre-mRNAs generate immune tolerance
por: Sroka, Ewa Maria, et al.
Publicado: (2023)

Potential Cellular Functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus
por: Smith, Danielle Westhoff, et al.
Publicado: (2013)

Nucleolin directly mediates Epstein-Barr virus immune evasion through binding to G-quadruplexes of EBNA1 mRNA
por: Lista, María José, et al.
Publicado: (2017)

Contributions of Epstein–Barr Nuclear Antigen 1 (EBNA1) to Cell Immortalization and Survival
por: Frappier, Lori
Publicado: (2012)

Nuclear processing of nascent transcripts determines synthesis of full-length proteins and antigenic peptides
por: Martins, Rodrigo Prado, et al.
Publicado: (2019)

A yeast model for the mechanism of the Epstein-Barr virus immune evasion identifies a new therapeutic target to interfere with the virus stealthiness
por: Lista, María José, et al.
Publicado: (2017)

The Epstein-Barr Virus EBNA1 Protein
por: Frappier, Lori
Publicado: (2012)

An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3)
Publicado: (1990)

Human Cd4(+) T Lymphocytes Consistently Respond to the Latent Epstein-Barr Virus Nuclear Antigen Ebna1
por: Münz, Christian, et al.
Publicado: (2000)

Lymphomas driven by Epstein-Barr virus nuclear antigen-1 (EBNA1) are dependant upon Mdm2
por: AlQarni, Sana, et al.
Publicado: (2018)

MHC II tetramers visualize human CD4(+) T cell responses to Epstein–Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response
por: Long, Heather M., et al.
Publicado: (2013)

Genome-wide analysis of host-chromosome binding sites for Epstein-Barr Virus Nuclear Antigen 1 (EBNA1)
por: Lu, Fang, et al.
Publicado: (2010)

Endogenous Presentation of CD8(+) T Cell Epitopes from Epstein-Barr Virus–encoded Nuclear Antigen 1
por: Tellam, Judy, et al.
Publicado: (2004)

PRIMA-1(MET )induces nucleolar translocation of Epstein-Barr virus-encoded EBNA-5 protein
por: Stuber, György, et al.
Publicado: (2009)

Epstein–Barr virus nuclear antigen (EBNA) 3A induces the expression of and interacts with a subset of chaperones and co-chaperones
por: Young, Paul, et al.
Publicado: (2008)

Transcription Profiling of Epstein-Barr Virus Nuclear Antigen (EBNA)-1 Expressing Cells Suggests Targeting of Chromatin Remodeling Complexes
por: Sompallae, Ramakrishna, et al.
Publicado: (2010)

Messenger RNA Sequence Rather than Protein Sequence Determines the Level of Self-synthesis and Antigen Presentation of the EBV-encoded Antigen, EBNA1
por: Tellam, Judy T., et al.
Publicado: (2012)

MHC Class II Auto-Antigen Presentation is Unconventional
por: Sadegh-Nasseri, Scheherazade, et al.
Publicado: (2015)

Involvement of autophagy in MHC class I antigen presentation
por: Øynebråten, Inger
Publicado: (2020)

Proteolysis and antigen presentation by MHC class II molecules
por: Bryant, Paula Wolf, et al.
Publicado: (2002)

Novel Patterns of the Epstein-Barr Nuclear Antigen (EBNA-1) V-Val Subtype in EBV-associated Nasopharyngeal Carcinoma from Vietnam
por: Thuan, LD, et al.
Publicado: (2019)

The actin-based motor protein myosin II regulates MHC class II trafficking and BCR-driven antigen presentation
por: Vascotto, Fulvia, et al.
Publicado: (2007)

Antigen Processing by Macroautophagy for MHC Presentation
por: Münz, Christian
Publicado: (2011)

Antigen processing for MHC presentation by autophagy
por: Münz, Christian
Publicado: (2010)

Antigen Presentation by MHC-Dressed Cells
por: Nakayama, Masafumi
Publicado: (2015)

High MHC-II expression in Epstein–Barr virus-associated gastric cancers suggests that tumor cells serve an important role in antigen presentation
por: Ghasemi, Farhad, et al.
Publicado: (2020)

Differential regulation of miR-21 and miR-146a by Epstein–Barr virus-encoded EBNA2
por: Rosato, P, et al.
Publicado: (2012)

Antigen Processing for MHC Class II Presentation via Autophagy
por: Münz, Christian
Publicado: (2012)

EBNA1: Oncogenic Activity, Immune Evasion and Biochemical Functions Provide Targets for Novel Therapeutic Strategies against Epstein-Barr Virus- Associated Cancers
por: Wilson, Joanna B., et al.
Publicado: (2018)

Epstein-Barr virus nuclear antigen EBNA-LP is essential for transforming naïve B cells, and facilitates recruitment of transcription factors to the viral genome
por: Szymula, Agnieszka, et al.
Publicado: (2018)

A Preliminary Sequence Analysis of the Epstein-Barr Virus Nuclear Antigen 1 (EBNA1) Carboxy-Terminal Region in Cervical and Ovarian Cancers
por: Hosseini Tabatabaie, Fatemeh, et al.
Publicado: (2023)

The Macroautophagy Machinery in MHC Restricted Antigen Presentation
por: Münz, Christian
Publicado: (2021)

Epstein-Barr virus encoded nuclear protein EBNA-3 binds a novel human uridine kinase/uracil phosphoribosyltransferase
por: Kashuba, Elena, et al.
Publicado: (2002)

The interaction of Epstein-Barr virus encoded transcription factor EBNA2 with multiple sclerosis risk loci is dependent on the risk genotype
por: Keane, Jeremy Thomas, et al.
Publicado: (2021)

Species-specific functions of Epstein-Barr virus nuclear antigen 2 (EBNA2) reveal dual roles for initiation and maintenance of B cell immortalization
por: Mühe, Janine, et al.
Publicado: (2017)

Correction: Epstein-Barr virus nuclear antigen EBNA-LP is essential for transforming naïve B cells, and facilitates recruitment of transcription factors to the viral genome
por: Szymula, Agnieszka, et al.
Publicado: (2019)

The Epstein-Barr virus EBNA1 protein modulates the alternative splicing of cellular genes
por: Boudreault, Simon, et al.
Publicado: (2019)

Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency
por: Dheekollu, Jayaraju, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8eeqdf41uvb191por3pp6ui378